Artelo Biosciences, Inc. SEC filings ARTL
Artelo Biosciences, Inc. has 465 filings in SEC EDGAR's recent list, going back to Oct 8, 2014. Its latest annual report, Form ARS, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 9, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 27, 2026 | Aug 26, 2026 |
| 10-Q/A | Amended quarterly report | Aug 20, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 17, 2026 | Jul 17, 2026 |
| DEFA14A | Additional proxy material | Jul 16, 2026 | — |
| DEFA14A | Additional proxy material | Jul 16, 2026 | — |
| DEFA14A | Additional proxy material | Jul 2, 2026 | — |
| PRER14A | Prer 14a | Jun 22, 2026 | — |
| ARS | Annual report to shareholders | Jun 5, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Jun 5, 2026 | — |
| DEF 14A | Proxy statement | Jun 5, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 27, 2026 | May 26, 2026 |
| PRE 14A | Preliminary proxy statement | May 26, 2026 | Jul 17, 2026 |
| 424B5 | Prospectus supplement | May 26, 2026 | — |
| EFFECT | Filing | May 19, 2026 | — |
| 424B5 | Prospectus supplement | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 15, 2026 | — |
| 8-K |
Current report
Agreement ended
|
May 15, 2026 | May 11, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| S-3/A | Form s-3/a | May 14, 2026 | — |
| UPLOAD | Letter from the SEC | May 11, 2026 | — |
| S-3 | Shelf registration | May 4, 2026 | — |
| 424B3 | Prospectus | Apr 16, 2026 | — |
| EFFECT | Filing | Apr 15, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2026 | — |
| S-1 | Registration statement | Apr 7, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 6, 2026 |
| D | Filing | Apr 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 3, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 27, 2026 |
| D | Filing | Mar 27, 2026 | — |
| D | Filing | Mar 27, 2026 | — |
| D | Filing | Mar 27, 2026 | — |
| RW | Form rw | Mar 27, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 26, 2026 | Mar 20, 2026 |
| EFFECT | Filing | Mar 25, 2026 | — |
| CORRESP | Letter to the SEC | Mar 25, 2026 | — |
| S-1 | Registration statement | Mar 24, 2026 | — |
| S-1/A | Amended registration statement | Mar 24, 2026 | — |
| S-1/A | Amended registration statement | Mar 23, 2026 | — |
| CORRESP | Letter to the SEC | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 20, 2026 | — |
| S-1 | Registration statement | Mar 20, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 18, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 17, 2026 | Mar 17, 2026 |
| UPLOAD | Letter from the SEC | Mar 13, 2026 | — |
| DRS | Filing | Mar 9, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 6, 2026 | Mar 5, 2026 |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| D | Filing | Feb 6, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 5, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Other events
|
Feb 5, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 16, 2026 | Jan 14, 2026 |
| DEFA14A | Additional proxy material | Jan 7, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 2, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Dec 11, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Dec 11, 2025 | Dec 31, 2025 |
| EFFECT | Filing | Dec 2, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| 8-K |
Current report
Listing notice
|
Nov 25, 2025 | Nov 19, 2025 |
| 3 | Initial insider ownership | Nov 17, 2025 | Nov 1, 2025 |
| S-1 | Registration statement | Nov 17, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 14, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| D | Filing | Nov 10, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 31, 2025 | Oct 28, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 28, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 28, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2025 | Oct 26, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 21, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 17, 2025 | — |
| 8-K |
Current report
Material agreement
|
Oct 17, 2025 | Oct 15, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 3, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 1, 2025 | Sep 29, 2025 |
| 424B5 | Prospectus supplement | Oct 1, 2025 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| DRS | Filing | Sep 29, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 19, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 15, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 10, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 5, 2025 | Sep 3, 2025 |
| 424B5 | Prospectus supplement | Sep 5, 2025 | — |
| 424B5 | Prospectus supplement | Sep 4, 2025 | — |
| 424B5 | Prospectus supplement | Sep 4, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Aug 29, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Agreement ended
|
Aug 20, 2025 | Aug 19, 2025 |
| D | Filing | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| DEF 14A | Proxy statement | Aug 7, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 7, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Aug 4, 2025 | Aug 1, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 28, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2025 | Jul 18, 2025 |
| 424B5 | Prospectus supplement | Jul 18, 2025 | — |
| EFFECT | Filing | Jul 17, 2025 | — |
| CORRESP | Letter to the SEC | Jul 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2025 | — |
| S-1 | Registration statement | Jul 11, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jul 11, 2025 | Jul 11, 2025 |
| D | Filing | Jul 9, 2025 | — |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 26, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Listing notice
|
May 23, 2025 | May 22, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 1, 2025 | Apr 27, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 29, 2025 | Apr 23, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 20, 2024 | Dec 20, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Nov 8, 2024 | — |
| DEF 14A | Proxy statement | Nov 8, 2024 | Dec 19, 2024 |
| ARS | Annual report to shareholders | Nov 8, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 25-NSE | Delisting notice | Jun 17, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 5, 2024 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 4, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 4, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 4, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 4, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 4, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 8, 2023 | Aug 4, 2023 |
| EFFECT | Filing | Jul 14, 2023 | — |
| CORRESP | Letter to the SEC | Jul 12, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2023 | — |
| DEL AM | Filing | Jul 7, 2023 | — |
| S-3 | Shelf registration | Jul 6, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 3, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| DEFA14A | Additional proxy material | May 16, 2023 | — |
| DEF 14A | Proxy statement | May 16, 2023 | May 5, 2023 |
| ARS | Annual report to shareholders | May 16, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| PRE 14A | Preliminary proxy statement | May 5, 2023 | Apr 14, 2023 |
| S-8 | Employee stock plan registration | Apr 21, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 21, 2023 | Apr 21, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 4 | Insider transaction | Feb 1, 2023 | Feb 1, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 16, 2022 | Sep 16, 2022 |
| 8-K |
Current report
Other events
|
Aug 25, 2022 | Aug 24, 2022 |
| 4 | Insider transaction | Aug 12, 2022 | Aug 12, 2022 |
| 4 | Insider transaction | Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 9, 2022 | Aug 8, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 12, 2022 | Jun 24, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1621221
- Former names
- REACTIVE MEDICAL INC. (until Apr 17, 2017); KNIGHT KNOX DEVELOPMENT CORP. (until Feb 6, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.